TME-SW
01698
XIAOMI-W
01810
BOSS ZHIPIN-W
02076
TENCENT
00700
JD HEALTH
06618
(Q6)Jun 30, 2024 | (FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | ---- | -72.60%29.5M | ---- | -49.82%107.68M | ---- | 98.67%214.56M | ---- | -23.57%108M | ---- | 1,286.85%141.31M |
Profit adjustment | ||||||||||
Interest (income) - adjustment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 81.68%-3.23M |
Dividend (income)- adjustment | ---- | 21.36%-12.84M | ---- | -143.18%-16.33M | ---- | -88.60%-6.71M | ---- | ---3.56M | ---- | ---- |
Investment loss (gain) | ---- | -17.00%-29.4M | ---- | -94.11%-25.13M | ---- | -187.43%-12.95M | ---- | -529.93%-4.5M | ---- | 60.99%-715K |
Attributable subsidiary (profit) loss | ---- | -253.94%-1.21M | ---- | 70.28%-343K | ---- | -155.31%-1.15M | ---- | -115.53%-452K | ---- | 203.23%2.91M |
Impairment and provisions: | ---- | --15.47M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Impairment of goodwill | ---- | --15.47M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Revaluation surplus: | ---- | -112.99%-5.61M | ---- | 1,360.56%43.15M | ---- | -71.26%2.95M | ---- | 445.86%10.28M | ---- | ---2.97M |
-Other fair value changes | ---- | -112.99%-5.61M | ---- | 1,360.56%43.15M | ---- | -71.26%2.95M | ---- | 445.86%10.28M | ---- | ---2.97M |
Asset sale loss (gain): | ---- | -151.52%-664K | ---- | -175.86%-264K | ---- | 635.38%348K | ---- | 99.38%-65K | ---- | -150,671.43%-10.54M |
-Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---10.52M |
-Loss (gain) on sale of property, machinery and equipment | ---- | -151.52%-664K | ---- | -175.86%-264K | ---- | 635.38%348K | ---- | -261.11%-65K | ---- | -357.14%-18K |
Depreciation and amortization: | ---- | -17.37%118.86M | ---- | 4.20%143.85M | ---- | 26.31%138.05M | ---- | 74.65%109.3M | ---- | 330.96%62.58M |
-Depreciation | ---- | 25.66%29.75M | ---- | 1.81%23.68M | ---- | 37.35%23.26M | ---- | 21.38%16.93M | ---- | 13.15%13.95M |
-Amortization of intangible assets | ---- | -58.99%21.2M | ---- | -3.09%51.68M | ---- | 12.10%53.33M | ---- | 440.74%47.57M | ---- | 301.37%8.8M |
Financial expense | ---- | 115.33%3.61M | ---- | -263.26%-23.54M | ---- | -60.50%14.42M | ---- | --36.5M | ---- | ---- |
Special items | ---- | -21.66%85.85M | ---- | 1.30%109.59M | ---- | -10.93%108.18M | ---- | 66.32%121.45M | ---- | 19.97%73.02M |
Operating profit before the change of operating capital | ---- | -39.89%203.57M | ---- | -26.01%338.66M | ---- | 21.42%457.69M | ---- | 43.67%376.94M | ---- | 291.23%262.36M |
Change of operating capital | ||||||||||
Accounts receivable (increase)decrease | ---- | 97.52%-2.05M | ---- | -533.96%-82.49M | ---- | 74.98%-13.01M | ---- | -69.72%-52.01M | ---- | -1.85%-30.64M |
Accounts payable increase (decrease) | ---- | -324.52%-127.44M | ---- | -68.91%56.76M | ---- | 157.73%182.54M | ---- | 308.76%70.83M | ---- | -42.20%17.33M |
prepayments (increase)decrease | ---- | -96.45%1.27M | ---- | 219.69%35.77M | ---- | ---29.89M | ---- | ---- | ---- | 56.80%-24.34M |
Special items for working capital changes | ---- | 79.45%-32.76M | ---- | -215.16%-159.41M | ---- | 29.24%138.42M | ---- | 326.88%107.1M | ---- | -87.01%25.09M |
Cash from business operations | 38.93%-110.42M | -77.50%42.6M | -4,188.09%-180.82M | -74.27%189.3M | -97.40%4.42M | 46.31%735.75M | 10,761.92%169.99M | 101.31%502.86M | -84.10%1.57M | 22.56%249.79M |
Other taxs | 47.09%-9.11M | 47.46%-24.27M | 45.33%-17.22M | -20.20%-46.19M | -19.04%-31.49M | -5.08%-38.43M | -28.33%-26.45M | -5,995.50%-36.57M | -4,660.74%-20.61M | -11,900.00%-600K |
Net cash from operations | 39.64%-119.53M | -87.19%18.33M | -631.61%-198.03M | -79.48%143.1M | -118.86%-27.07M | 49.55%697.32M | 853.50%143.54M | 87.12%466.29M | -302.50%-19.05M | 22.27%249.19M |
Cash flow from investment activities | ||||||||||
Dividend received - investment | ---- | -20.39%13.12M | ---- | 134.92%16.48M | ---- | 97.02%7.01M | ---- | --3.56M | ---- | ---- |
Loan receivable (increase) decrease | ---- | ---- | ---- | ---- | ---- | --3.86M | ---- | ---- | ---- | ---10.99M |
Decrease in deposits (increase) | ---- | 1,144.39%423.06M | ---- | -47.31%34M | ---- | -65.15%64.53M | ---- | -52.36%185.13M | ---- | 118.11%388.63M |
Sale of fixed assets | ---- | -88.51%67K | ---- | 488.89%583K | ---- | -82.60%99K | ---- | 331.06%569K | ---- | 11.86%132K |
Purchase of fixed assets | -26.28%-10.54M | 49.46%-12.54M | 9.93%-8.35M | 30.24%-24.81M | 2.95%-9.27M | -85.77%-35.57M | -8.82%-9.55M | -15.95%-19.15M | 30.65%-8.78M | 14.81%-16.51M |
Recovery of cash from investments | -54.19%346.59M | -7.94%785.62M | -9.17%756.56M | 167.95%853.42M | 73.10%832.97M | 182.16%318.5M | 14.25%481.22M | -23.55%112.88M | --421.2M | -38.85%147.65M |
Cash on investment | 6.71%-297.12M | 14.16%-694.43M | 55.17%-318.5M | 5.17%-808.94M | -20.30%-710.5M | -197.17%-853M | -43.98%-590.6M | -70.08%-287.04M | ---410.2M | 44.72%-168.77M |
Other items in the investment business | -27.62%19.5M | ---- | 164.25%26.95M | 82.26%-10.05M | 68.49%-41.94M | 34.65%-56.64M | -421.55%-133.13M | 89.62%-86.67M | -135.63%-25.53M | ---835.22M |
Net cash from investment operations | -87.20%58.43M | 748.59%514.89M | 540.85%456.66M | 111.01%60.68M | 128.27%71.26M | -507.62%-551.21M | -981.77%-252.06M | 81.68%-90.72M | -139.50%-23.3M | 77.79%-495.09M |
Net cash before financing | -123.62%-61.1M | 161.67%533.22M | 485.25%258.63M | 39.47%203.78M | 140.72%44.19M | -61.10%146.11M | -156.27%-108.53M | 252.74%375.57M | -161.92%-42.35M | 87.86%-245.89M |
Cash flow from financing activities | ||||||||||
New borrowing | -44.95%56.52M | 78.05%107.37M | 211.16%102.68M | 2,009.97%60.3M | 1,000.00%33M | -97.91%2.86M | -97.82%3M | 132.20%137M | --137.45M | -83.27%59M |
Refund | 49.71%-15.75M | -85.78%-95.86M | -42.34%-31.32M | -1,619.93%-51.6M | ---22M | 98.47%-3M | ---- | ---196M | ---- | ---- |
Issuing shares | ---- | 313.85%9.54M | ---- | -58.15%2.3M | ---- | 1,099.35%5.51M | ---- | -89.00%459K | ---- | --4.17M |
Interest paid - financing | 41.07%-2.44M | 1.77%-8.26M | -27.39%-4.14M | -21.11%-8.41M | 4.69%-3.25M | 26.82%-6.94M | ---3.41M | -68.72%-9.49M | ---- | -219.91%-5.62M |
Dividends paid - financing | ---100.2M | 51.18%-10.72M | ---- | -67.07%-21.95M | ---- | ---13.14M | ---- | ---- | ---- | ---- |
Absorb investment income | ---- | ---- | ---- | -92.19%152K | ---- | --1.95M | ---- | ---- | ---- | -99.96%980K |
Other items of the financing business | 99.74%-660K | -108.37%-283.4M | -135.23%-252.35M | -45.31%-136.01M | -204.23%-107.28M | 10.90%-93.6M | 5.73%-35.26M | -17.79%-105.05M | -1.27%-37.41M | -23,872.31%-89.18M |
Net cash from financing operations | 56.90%-91.65M | -51.59%-343.33M | -56.12%-212.64M | -36.13%-226.48M | -111.53%-136.21M | 22.92%-166.38M | -164.36%-64.39M | -212.30%-215.86M | 370.85%100.05M | -102.94%-69.12M |
Effect of rate | -59.91%801K | -89.20%368K | -26.73%2M | 477.30%3.41M | 0.93%2.73M | 52.97%-903K | 48.62%2.7M | -107.43%-1.92M | 8.21%1.82M | -63.37%25.84M |
Net Cash | -432.12%-152.75M | 936.35%189.89M | 149.98%45.99M | -12.05%-22.7M | 46.79%-92.02M | -112.69%-20.26M | -399.71%-172.92M | 150.70%159.71M | 83.43%57.7M | -196.50%-315.02M |
Begining period cash | 39.93%666.73M | -3.89%476.48M | -3.89%476.48M | -4.09%495.78M | -4.09%495.78M | 43.93%516.94M | 43.93%516.94M | -44.60%359.16M | -44.60%359.16M | 157.94%648.33M |
Cash at the end | -1.85%514.79M | 39.93%666.73M | 29.02%524.47M | -3.89%476.48M | 17.24%406.49M | -4.09%495.78M | -17.18%346.73M | 43.93%516.94M | -38.56%418.67M | -44.60%359.16M |
Cash balance analysis | ||||||||||
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
Auditor | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG | -- | KPMG |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.